[My recent post on this topic here.] (29:18): The ability to assess thousands of proteins in each individual, and it's giving us new insights about cause and effect as you alluded to, the relationship with as you said, MACE (major adverse cardiovascular events) and the actions of this drug class
Christopher Newgard (Duke University, USA)
J Hepatol (2015) 62:S4764
Retatrutide is an investigational peptide medication which is being developed for obesity and metabolic disease management
Finally, beyond their role in controlling metabolic processes, GLP-1 receptor agonists also show promising potential benefits in treating cardiovascular and neurodegenerative diseases
For FIP cats, we recommend a weekly injection until the anemia resolves and RBC values are stable